Incorporating circadian biology into drug development can enhance therapeutic outcomes. By understanding the SCN's role in regulating biological rhythms, researchers can identify optimal times for drug administration, reducing side effects and improving efficacy. This approach, known as chronopharmacology, leverages the circadian system to tailor treatments to an individual's biological clock, potentially transforming personalized medicine.
